These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3788960)

  • 1. Is sickle cell crisis a thrombotic event?
    Green D; Scott JP
    Am J Hematol; 1986 Dec; 23(4):317-21. PubMed ID: 3788960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
    Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
    Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
    Mourad H; Fadel W; El Batch M; Rowisha M
    Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
    Ekwere TA; Ebele U; Ekanem M; Ogunro PS
    Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
    Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
    Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor XIII concentration in sickle-cell disease.
    Ittyerah R; Alkjaersig N; Fletcher A; Chaplin H
    J Lab Clin Med; 1976 Oct; 88(4):546-54. PubMed ID: 965808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
    Francis RB
    Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in sickle cell disease during steady state.
    Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic alterations accompanying sickle cell pain crises.
    Alkjaersig N; Fletcher A; Joist H; Chaplin H
    J Lab Clin Med; 1976 Sep; 88(3):440-9. PubMed ID: 956696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls.
    Hagger D; Wolff S; Owen J; Samson D
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):93-9. PubMed ID: 7605884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
    Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against enhanced platelet activity in sickle cell anaemia.
    Buchanan GR; Holtkamp CA
    Br J Haematol; 1983 Aug; 54(4):595-603. PubMed ID: 6223655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease.
    Devine DV; Kinney TR; Thomas PF; Rosse WF; Greenberg CS
    Blood; 1986 Jul; 68(1):317-9. PubMed ID: 3719103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.